2nd Quarter - Report
KING & SPALDING LLP for AMARIN PHARMA, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 19, 2016 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Oct 4, 2018 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Insurance formulary coverage of unregulated dietary supplements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL F DONOVAN | Senate Committees on Finance, Small Business, and Government Affairs |
| DAVID JOSEPH FARBER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.